Implication for health policy/practice/research/medical education:
Clinical care should focus on increasing dietary magnesium intake or magnesium supplementation to improve metabolic control and prevent dyslipidemia in diabetes individuals.
Diabetes mellitus is a major public health problem thought the world and is growing in populations (1). Previously, we studied the correlation of serum lipids with serum magnesium value in diabetes patients in on 122. In this study we observed, a significant inverse association of serum magnesium level with serum cholesterol and LDL-C (2). Likewise, in the study conducted by Dasgupta et al. on one hundred and fifty, diabetic patients, hypomagnesemia was detected in 11.33% of patients. They observed that hypomagnesaemia in diabetes was correlated with poorer glycemic control nephropathy and retinopathy (3). Ahmed Baig et al. conducted a study on 60 diabetic patients. They found that the mean serum magnesium value was significantly low in diabetic patients without and with complications when compared with control group. Also, they observed that serum magnesium level in cases with diabetic complications was much lower than those without complications (4). Accordingly, Kocot et al. conducted an investigation on 54 diabetic patients. They found, low serum value of magnesium in diabetic subjects in comparison to healthy individuals. They also found, a weak negative association between plasma magnesium and total cholesterol and between serum magnesium and triglycerides in diabetic patients (5). This result attests our previous results (1-4). More recently Mishra et al. studied 45 diabetic patients. They found a significant negative correlation of serum magnesium with triglyceride and VLDL-C level and a positive association of magnesium with serum HDL-C too (6). The correlation of hypomagnesemia and insulin resistance in diabetes patients has been documented previously too (7-9). Similarly in the study of 219 diabetic individuals, Rasheed et al. observed, serum magnesium had significantly positive association with HDL-cholesterol, while total cholesterol and LDL-cholesterol was negatively associated, albeit non-significantly, with serum magnesium (10). Moreover, an investigation on 550 diabetic patients, showed serum magnesium had significant negative association with glomerular filtration rate (8). Therefore, clinical care should focus on increasing dietary magnesium intake or magnesium supplementation to improve metabolic control and prevent dyslipidemia in diabetes individuals (6-10).
Authors’ contributions
All authors wrote the manuscript equally.
Conflict of interests
The author declared no competing interests.
Ethical considerations
Ethical issues (including plagiarism, data fabrication, double publication) have been completely observed by the author.
Funding/Support
None.
Please cite this paper as: Ghorbani A, Baradaran A.Magnesium and diabetes mellitus. J Renal Inj Prev 2012; 1(2):46-47. DOI: 10.12861/jrip.2012.16
References
- 1.Díaz-Domínguez ME, Fernández-Lucas M, Gomis-Couto A, Ruiz-Roso G, Teruel JL, Quereda C. Effects of suspending ACE inhibitors and ARBs in advanced chronic kidney disease. Nefrologia. 2012;32(3):400–1. doi: 10.3265/Nefrologia.pre2012.Mar.11422. [DOI] [PubMed] [Google Scholar]
- 2.Nasri H, Baradaran HR. Lipids in association with serum magnesium in diabetes mellitus patients. Bratisl Lek Listy. 2008;109:302–6. [PubMed] [Google Scholar]
- 3.Dasgupta A, Sarma D, Saikia UK. Hypomagnesemia in type 2 diabetes mellitus. Indian J Endocrinol Metab. 2012;16:1000–3. doi: 10.4103/2230-8210.103020. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Ahmed Baig MS, Shamshuddin M, Mahadevappa KL, Attar AH, Shaikh AK. Serum Magnesium as a Marker of Diabetic Complications. Journal of Evolution of Medical and Dental Sciences. 2012;1:119–23. [Google Scholar]
- 5.Kocot DL, Sztanke M, Wiśniewska MN, Da̧browski A, Andrzejewski A, Wallner G. et al. Plasma magnesium and calcium concentrations and selected biochemical parameters in patients with type 2 diabetes mellitus. Curr Issues Pharm Med. 2012;25:126–31. [Google Scholar]
- 6.Mishra S, Padmanaban P, Deepti GP, Sarkar G, Sumathi G, Toora BD. Serum Magnesium and Dyslipidemia in Type-2 Diabetes Mellitus. Biomedical Research. 2012;23:295–300. [Google Scholar]
- 7.Srinivasan AR, Niranjan G, Kuzhandai Velu V, Parmar P, Anish A. Status of serum magnesium in type 2 diabetes mellitus with particular reference to serum triacylglycerol levels. Diabetes Metab Syndr. 2012;6:187–9. doi: 10.1016/j.dsx.2012.09.001. [DOI] [PubMed] [Google Scholar]
- 8.Pham PC, Pham PM, Pham PT. Patients with diabetes mellitus type 2 and hypomagnesemia may have enhanced glomerular filtration via hypocalcemia. Clin Nephrol. 2012;78:442–8. doi: 10.5414/CN107525. [DOI] [PubMed] [Google Scholar]
- 9.Weng LC, Lee NJ, Yeh WT, Ho LT, Pan WH. Lower intake of magnesium and dietary fiber increases the incidence of type 2 diabetes in Taiwanese. Formos Med Assoc. 2012;111:651–9. doi: 10.1016/j.jfma.2012.07.038. [DOI] [PubMed] [Google Scholar]
- 10.Rasheed H, Elahi S, Ajaz H. Serum magnesium and atherogenic lipid fractions in type II diabetic patients of Lahore, Pakistan. Biol Trace Elem Res. 2012;148:165–9. doi: 10.1007/s12011-012-9361-5. [DOI] [PubMed] [Google Scholar]